HCV New Drugs

This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.

Risk Of Developing Liver Cancer After HCV Treatment

▼

Showing posts with label AASLD 2015 updated hepatitis C practice guidelines. Show all posts

Showing posts with label AASLD 2015 updated hepatitis C practice guidelines. Show all posts

Thursday, September 17, 2015

Pediatric HCV: Small Patients, Big Decisions

Pediatric HCV: Small Patients, Big Decisions Hi everyone, the September 2015 digital edition of HCV Next is now available for your vi...

Sunday, August 23, 2015

AASLD/IDSA Update - HCV guidance for Cost, Reimbursement and Cost-Effectiveness Considerations

The American Association for the Study of Liver Diseases (AASLD), in partnership with the Infectious Diseases Society of America (IDSA) ...

Thursday, August 6, 2015

AASLD/IDSA Guidlines Updated: When and In Whom to Initiate Therapy

The American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) with the Internat...

Thursday, June 25, 2015

AASLD updates guidance for use of hepatitis C drugs

AASLD updates guidance for use of hepatitis C drugs The American Association for the Study of Liver Diseases (AASLD), in partnership with t...

View web version

Powered by Blogger.